Enhancing Prospective Thinking in Early Recovery

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT05835921
Status
Recruiting
Apply to this trial

Conditions

  • Stimulant Use
  • Substance Use Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Virtual Reality — DEVICE
    They will receive a Virtual Reality Park experience, which is an empty park with no avatars. They will then have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.
  • Virtual Reality — DEVICE
    They will receive a Virtual Reality Park experience, which is an empty park with no avatars.

Study Details

The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering stimulant use disorder (SUD) persons. The main question\[s\] this trial aims to answer are: Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.

Key Dates

Start date
Mar 28, 2023
Status verified
Mar 2026
Primary completion
May 1, 2026
Completion
May 1, 2026

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Virtual Reality
    Participants in this arm will receive the following interventions: Virtual Reality Park Virtual Reality Avatar
  • Placebo Comparator: Treatment As Usual
    Participants in this arm will receive the following interventions: Virtual Reality Park

Primary Outcome Measure

Reduced Use of Drug Using Days [ Time Frame: Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University School of Medicine - Goodman HallIndianapolisIndiana46202
Sarah Turo, MSW
[email protected]
317-963-7220
Brandon G Oberlin, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Indianapolis, IN

By research site
Indiana University School of Medicine - Goodman Hall· Indianapolis, IN

Related Studies